Intermediate-term outcomes of 350-mm2 Baerveldt glaucoma implants
- 31 March 2001
- journal article
- Published by Elsevier BV in Ophthalmology
- Vol. 108 (3), 621-626
- https://doi.org/10.1016/s0161-6420(00)00537-6
Abstract
Objective To determine the intermediate-term outcome of 350-mm2 Baerveldt glaucoma implants. Design Retrospective, noncomparative case series. Participants Sixty-five patients (65 eyes). Intervention Implantation of 350-mm2 Baerveldt glaucoma drainage device. Main outcome measures Intraocular pressure, number of glaucoma medications, best-corrected Snellen visual acuity, length of follow-up, risk factors for failure, and complications. Results Mean intraocular pressure was reduced from a preoperative value of 32 mmHg to a 2-year postoperative value of 14 mmHg (56% reduction, P < 0.001). Success rates at 2-year follow-up were 71%, 81%, 78%, 60%, and 47% for the overall group, primary open-angle glaucoma group, neovascular group, uveitic group, and other group, respectively. After accounting for the effect of diagnosis group, significant risk factors in the overall group for failure at 2 years included younger age, high preoperative intraocular pressure, and more prior incisional surgeries. Glaucoma medication use in our overall study population was reduced from 2.5 mean preoperative medications to 0.8 postoperative medications (68%). Median change in Snellen visual acuity between preoperative and 2-year postoperative visits was not significant in the overall group. Postoperative complications included choroidal effusion in 15 patients (23%), tube obstruction by blood or vitreous in five patients (8%), phthisis in four patients (6%), aqueous misdirection in two patients (3%), strabismus in two patients (3%), tube–cornea touch in two patients (3%), endophthalmitis in two patients (3%), and retinal detachment in two patients (3%). No patients had suprachoroidal hemorrhage. Conclusions The 350-mm2 Baerveldt glaucoma implants are a safe and effective treatment for intermediate-term intraocular pressure control in patients with refractory glaucoma.Keywords
This publication has 15 references indexed in Scilit:
- Follow-up of the original cohort with the Ahmed glaucoma valve implant11The views expressed herein are those of the authors and are not the official opinions of the Department of the Navy, the Department of Defense, or the United States Government.American Journal of Ophthalmology, 1999
- Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant 11The authors have no proprietary interest in the Ahmed Glaucoma Valve implant.American Journal of Ophthalmology, 1999
- Molteno Implant With Mitomycin CJournal of Glaucoma, 1998
- Long-term Survival of Molteno Glaucoma Drainage DevicesOphthalmology, 1996
- Clinical Experience with the Baerveldt Glaucoma Drainage ImplantOphthalmology, 1995
- Comparison of the Baerveldt Glaucoma Implant With the Double-Plate Molteno Drainage ImplantAmerican Journal of Ophthalmology, 1995
- Intermediate-term Results of a Randomized Clinical Trial of the 350- versus- the 500-mm2 Baerveldt ImplantOphthalmology, 1994
- Which Is Better? One or Two?Ophthalmology, 1992
- Clinical Experience with the Single-plate Molteno Implant in Complicated GlaucomasOphthalmology, 1992
- New implant for drainage in glaucoma. Clinical trial.British Journal of Ophthalmology, 1969